BRPI1000802B8 - process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles - Google Patents
process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticlesInfo
- Publication number
- BRPI1000802B8 BRPI1000802B8 BRPI1000802A BRPI1000802A BRPI1000802B8 BR PI1000802 B8 BRPI1000802 B8 BR PI1000802B8 BR PI1000802 A BRPI1000802 A BR PI1000802A BR PI1000802 A BRPI1000802 A BR PI1000802A BR PI1000802 B8 BRPI1000802 B8 BR PI1000802B8
- Authority
- BR
- Brazil
- Prior art keywords
- matrix microparticles
- microparticles
- aerial parts
- copaiferous
- langsdorffii
- Prior art date
Links
- 239000011859 microparticle Substances 0.000 title abstract 7
- 239000011159 matrix material Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 4
- 241000349999 Copaifera Species 0.000 abstract 3
- 208000000913 Kidney Calculi Diseases 0.000 abstract 3
- 206010029148 Nephrolithiasis Diseases 0.000 abstract 3
- -1 anti-inflammatory Substances 0.000 abstract 3
- 230000000202 analgesic effect Effects 0.000 abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- 230000002421 anti-septic effect Effects 0.000 abstract 2
- 230000002921 anti-spasmodic effect Effects 0.000 abstract 2
- 239000000812 cholinergic antagonist Substances 0.000 abstract 2
- 239000002934 diuretic Substances 0.000 abstract 2
- 230000001882 diuretic effect Effects 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 238000002955 isolation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000006558 Dental Calculus Diseases 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 208000007101 Muscle Cramp Diseases 0.000 abstract 1
- 208000000112 Myalgia Diseases 0.000 abstract 1
- 206010038478 Renal lithiasis Diseases 0.000 abstract 1
- 230000003187 abdominal effect Effects 0.000 abstract 1
- 230000002690 anti-lithiasic effect Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 208000013465 muscle pain Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
processo de obtenção de micropartículas matriciais de copaífera langsdoffíi (partes aéreas) e isolamento dos princípios ativos; micropartículas e compostos assim obtidos, com atividade antilitiásica (cálculo renal), analgésica, anti-espasmódica, anti-inflamatória, diurética e anti-séptica, suas formulações, produtos e usos. refere-se o presente invento a um processo de obtenção de micropartículas matriciais de copaifera iangsdorffii (partes aéreas) e do isolamento dos compostos ativos e/ou marcadores das partes aéreas da referida planta, bem como as atividades biológicas encontradas para tais micropartículas matriciais e dos compostos isolados, quais sejam: atividade antilitiásica (cálculo renal), analgésica, anti-espasmódica, anti-inflamatória, diurética e anti-séptica, bem como a utilização destes nos tratamentos de litíase renal (cálculo renal), artrites, tártaros, dores musculares e espasmódicas em geral (cólicas abdominais, renais, etc.). refere-se também as demais doenças relacionadas às atividades previamente citadas, além das formulações que podem ser originadas com as micropartículas matriciais de copaifera iangsdorffii; e/ou seus compostos isolados, como medicamentos, produtos de higiene pessoal, cosméticos, alimentos, produtos veterinários e odontológicos, etc.process for obtaining matrix microparticles of langsdoffii copaifera (aerial parts) and isolation of the active principles; microparticles and compounds thus obtained, with antilithiasic (kidney calculus), analgesic, antispasmodic, anti-inflammatory, diuretic and antiseptic activity, their formulations, products and uses. the present invention relates to a process for obtaining copaifera iangsdorffii matrix microparticles (aerial parts) and the isolation of active compounds and/or markers from the aerial parts of said plant, as well as the biological activities found for such matrix microparticles and the isolated compounds, namely: antilithiasis (kidney calculus), analgesic, antispasmodic, anti-inflammatory, diuretic and antiseptic activity, as well as their use in the treatment of renal lithiasis (kidney calculus), arthritis, tartars, muscle pain and spasmodic in general (abdominal, kidney cramps, etc.). it also refers to other diseases related to the activities previously mentioned, in addition to the formulations that can be originated with the copaifera iangsdorffii matrix microparticles; and/or its isolated compounds, such as medicines, personal care products, cosmetics, foods, veterinary and dental products, etc.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1000802A BRPI1000802B8 (en) | 2010-03-30 | 2010-03-30 | process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles |
| PCT/BR2011/000090 WO2011120118A1 (en) | 2010-03-30 | 2011-03-29 | Method for preparing matrix micro-particles of copaífera langsdorffii (aerial parts) and for isolating the active principles therein; thus prepared analgesic, anti-spasmodic, anti-inflammatory, diuretic and antiseptic micro-particles and compounds with anti-lithiasis activity (renal calculi), formulations, products and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1000802A BRPI1000802B8 (en) | 2010-03-30 | 2010-03-30 | process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI1000802A2 BRPI1000802A2 (en) | 2011-11-22 |
| BRPI1000802B1 BRPI1000802B1 (en) | 2020-12-29 |
| BRPI1000802B8 true BRPI1000802B8 (en) | 2021-09-08 |
Family
ID=44711247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1000802A BRPI1000802B8 (en) | 2010-03-30 | 2010-03-30 | process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles |
Country Status (2)
| Country | Link |
|---|---|
| BR (1) | BRPI1000802B8 (en) |
| WO (1) | WO2011120118A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12021550070A1 (en) * | 2018-07-10 | 2022-03-21 | Resorcix Ltd | Composition for inactivation of gram-positive bacteria and bacterial spores and mehtods of making and using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6753017B2 (en) * | 2001-11-07 | 2004-06-22 | Jrs Pharma Lp | Process for preparing dry extracts |
| BRPI0401631A (en) * | 2004-04-22 | 2005-12-06 | Aurita Rodrigues Fl Brunharoto | Process for obtaining and using extracts, fractions and substances isolated from copafera species in the treatment of urolithiasis in humans and animals |
-
2010
- 2010-03-30 BR BRPI1000802A patent/BRPI1000802B8/en active IP Right Grant
-
2011
- 2011-03-29 WO PCT/BR2011/000090 patent/WO2011120118A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011120118A1 (en) | 2011-10-06 |
| BRPI1000802B1 (en) | 2020-12-29 |
| BRPI1000802A2 (en) | 2011-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014009851A2 (en) | nmda receptor modulators and uses thereof | |
| MX2010004613A (en) | Topical composition. | |
| BR112012016575A2 (en) | skin care composition / dermatological, plant-produced heterologous growth factor, and method for making a topical product | |
| BR112014031730A2 (en) | chemical entities, pharmaceutical compositions, pharmaceutically acceptable compounds or salts thereof, uses of chemical entities or compositions and methods for treating diseases, disorders or medical conditions mediated by pde1 enzymatic activity and for modulating pde1 enzyme activity | |
| EA201101424A1 (en) | ANTIMICROBIAL COMPOSITIONS AND METHODS OF THEIR APPLICATION | |
| BRPI1010861A8 (en) | methods for treating pain, inflammation or osteoarthritis, package and pharmaceutical formulation | |
| BRPI0720500A8 (en) | TRANSDERMAL LIQUID PREPARATION | |
| BR112015005339A8 (en) | use of miracle fruit seed oil as an active ingredient | |
| EA201270615A1 (en) | ANTIGROUSE PREPARATION CONTAINING FUNGAL ORGANISM | |
| AR054249A1 (en) | TREATMENT OF SKIN CONNECTIVE TISSUE DISEASES | |
| FI20095606A7 (en) | System and method for producing a solution with low suspended solids content and use of such a solution | |
| EA201390345A1 (en) | THERAPEUTIC HOSE MEDICINE | |
| BR112015012057A2 (en) | fungicidal binary mixtures | |
| BRPI1000802B8 (en) | process for obtaining langsdorffii copaiferous matrix microparticles (aerial parts) and langsdorffii copaiferous matrix microparticles | |
| Vaishnav et al. | Unlocking the Medicinal Treasure of Cinnamomum Tamala (Bay Leaf): A Comprehensive Review of its Therapeutic and Pharmaceutical Potential | |
| ES2387109B1 (en) | PHARMACEUTICAL SPRAYING | |
| MX2016007973A (en) | Topical composition comprising natural ingredients for bruising or hematoma healing on skin and use thereof. | |
| Jahan et al. | Antioxidant activity of gemmo therapeutically treated indiginous medicinal plants | |
| Avanti et al. | Plantago major synthesized silver nanoparticles in an anti-acne facial sheet mask: physical stability, safety, and efficacy | |
| CN101658538A (en) | Medicament for treating scalds | |
| CN105434431A (en) | Multifunctional externally applied antibacterial preparation, and preparing method and application thereof | |
| GB2436524A (en) | Topical composition comprising an extract of the butterbur plant | |
| Johnston | Muscle and joint pain: topical anti-inflammatories and analgesics: therapeutic | |
| BR112014032850A2 (en) | combinations of active ingredients, cosmetic or dermatological preparations, and use of combinations of active ingredients | |
| Borthakur | Treatment of diseases in the Atharvaveda: an observation. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/03/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2608 DE 29/12/2020 QUANTO AO ENDERECO. |